Market cap
₹541 Cr
Revenue (TTM)
₹107 Cr
P/E Ratio
29.8
P/B Ratio
3.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 0.87 | 0.94 | 13.68 |
| EBIT | -- | -- | -17.72 | 11.87 | 31.62 |
| Net Profit | -- | -- | -17.02 | 20.79 | 56.80 |
| EPS | -- | -- | -17.02 | -18.56 | 23.77 |
| Book Value | -- | -- | 14.82 | 13.66 | 19.23 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 8.37 | 6.91 | 7.20 | -- | -- |
| Net Margin
| 7.68 | 5.86 | 7.20 | -- | -- |
| Return on equity
| 26.90 | 27.42 | 12.73 | -- | -- |
| Return on Capital
| 30.53 | 27.77 | 13.58 | -- | -- |
| Return on Assets
| 10.43 | 8.70 | 5.43 | -- | -- |
| Debt to Equity (x)
| -- | -- | 0.49 | -- | -- |
Profitability
ROCE
13.58
Lower than Peers by 0.05
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
13.58
|
--
|
--
|
--
|
--
|
|
Peer Median
|
13.63
|
14.04
|
24.85
|
28.00
|
--
|
ROE
12.73
Higher than Peers by 3.47
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
12.73
|
--
|
--
|
--
|
--
|
|
Peer Median
|
9.26
|
10.34
|
18.61
|
20.97
|
--
|
ROA
5.43
Lower than Peers by 2.54
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
5.43
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.97
|
9.40
|
16.91
|
18.84
|
--
|
EBIT Margin
7.20
Lower than Peers by 8.67
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
7.20
|
--
|
--
|
--
|
--
|
|
Peer Median
|
15.86
|
15.92
|
27.87
|
33.10
|
--
|
Net Margin
7.20
Lower than Peers by 6.04
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
7.20
|
--
|
--
|
--
|
--
|
|
Peer Median
|
13.24
|
20.21
|
26.20
|
27.71
|
--
|
Cash Profit Margin
8.88
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
8.88
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-0.85
|
47.31
|
2.16
|
30.37
|
--
|
Net Profit Growth
--
--
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-9.57
|
-3.20
|
-7.87
|
27.36
|
--
|
EPS Growth
--
--
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-9.60
|
-6.25
|
-7.35
|
-100.00
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.49
Higher than Peers by 0.45
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
0.49
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.04
|
0.00
|
0.00
|
0.00
|
--
|
Short term debt to equity ratio
0.05
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
0.05
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.45
Lower than Peers by 2.59
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
1.45
|
--
|
--
|
--
|
--
|
|
Peer Median
|
4.04
|
9.46
|
10.05
|
10.00
|
--
|
Quick Ratio
0.75
Lower than Peers by 2.51
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
0.75
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.26
|
2.85
|
5.46
|
5.88
|
--
|
Interest Coverage
5.50
Lower than Peers by 38.73
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
5.50
|
--
|
--
|
--
|
--
|
|
Peer Median
|
44.23
|
142.61
|
309.77
|
392.33
|
--
|
Operating Efficiency
Debtors to sales
19.11
Lower than Peers by 7.89
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
19.11
|
--
|
--
|
--
|
--
|
|
Peer Median
|
27.00
|
26.61
|
29.53
|
25.19
|
--
|
Asset Turnover
0.72
Higher than Peers by 0.21
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
0.72
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.51
|
0.60
|
0.51
|
1.13
|
--
|
Receivable days
69.76
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
69.76
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
147.65
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
147.65
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
187.95
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
187.95
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
29.46
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
29.46
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
12.94
Lower than Peers by 35.55
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
12.94
|
--
|
--
|
--
|
--
|
|
Peer Median
|
48.49
|
46.25
|
25.22
|
45.36
|
--
|
Price / Book Value
1.65
Lower than Peers by 2.05
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
1.65
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.70
|
3.77
|
3.41
|
7.91
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.88
|
0.99
|
--
|
--
|
--
|
EV/EBITDA
8.83
Lower than Peers by 23.90
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
8.83
|
--
|
--
|
--
|
--
|
|
Peer Median
|
32.73
|
33.75
|
16.23
|
42.14
|
--
|
Market Cap
104
Lower than Peers by 33,769
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Hemant Surgical
|
104
|
--
|
--
|
--
|
--
|
|
Peer Median
|
33,873
|
33,401
|
25,958
|
53,713
|
--
|